drugset / Trial / NCT05086289
Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Chronic Low Back Pain
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to test whether LY3526318 is efficacious and safe in relieving chronic low back pain (CLBP). This trial is part of the chronic pain master protocol H0P-MC-CPMP (NCT05986292) which is a protocol to accelerate the development of new treatments for chronic pain.
Timeline
- Start
- 2021-10-25
- Primary completion
- 2022-06-17
- Completion
- 2022-06-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY3526318 | Unknown | 250 mg | Oral |